Christopher Simon

2021

In 2021, Christopher Simon earned a total compensation of $8.6M as President and Chief Executive Officer at Haemonetics, a 8% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,038,461
Option Awards$1,499,979
Salary$963,173
Stock Awards$5,096,181
Other$27,600
Total$8,625,394

Simon received $5.1M in stock awards, accounting for 59% of the total pay in 2021.

Simon also received $1M in non-equity incentive plan, $1.5M in option awards, $963.2K in salary and $27.6K in other compensation.

Rankings

In 2021, Christopher Simon's compensation ranked 1,301st out of 12,375 executives tracked by ExecPay. In other words, Simon earned more than 89.5% of executives.

ClassificationRankingPercentile
All
1,301
out of 12,375
90th
Division
Manufacturing
458
out of 5,489
92nd
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
52
out of 795
94th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
27
out of 516
95th
Industry
Surgical and Medical Instruments and Apparatus
16
out of 324
95th

Pay ratio

Christopher Simon's Pay$8,625,394
Median Employee's Pay$39,767
Pay Ratio

217

to 1

In 2021, the annual total compensation of Christopher Simon was $8,625,394.

The annual total compensation of the median employee at Haemonetics was $39,767.

The ratio of Christopher Simon's pay to the pay of median employee was therefore 217 to one.

Source: SEC filing on June 17, 2021.

Simon's colleagues

We found four more compensation records of executives who worked with Christopher Simon at Haemonetics in 2021.

2021

William Burke

Haemonetics

Chief Financial Officer

2021

Michelle Basil

Haemonetics

General Counsel

2021

Anila Lingamneni

Haemonetics

Executive Vice President, Chief Technogy Officer

2021

Josep Llorens

Haemonetics

Senior Vice President, Global Manufacturing and Supply Chain

News

You may also like